Sanna Iivanainen

Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors

Sanna Iivanainen, Jarkko Ahvonen, Aija Knuuttila et al. · ESMO Open · 2019 · 90 citations · Full text

Medicine, Immunology, Oncology +17

Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer

Abdul Rafeh Naqash, Justin McCallen, Emma Mi et al. · Journal for ImmunoTherapy of Cancer · 2023 · 55 citations · Full text

Life Sciences, Immunology, Oncology +14

Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients

Oliver Schmalz, Christine Jacob, Johannes Ammann et al. · Journal of Medical Internet Research · 2020 · 53 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study

Sanna Iivanainen, Tuomo Alanko, Katriina Peltola et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 49 citations · Full text

Medicine, Oncology, Cancer Symptom Management +12

Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies

Sanna Iivanainen, Jussi Ekström, Henri Virtanen et al. · BMC Medical Informatics and Decision Making · 2021 · 42 citations · Full text

Medicine, Immunology, Oncology +17